Gilead Sciences, Inc. (Nasdaq: GILD) today announced details of new clinical and real-world data from its innovative HIV treatment and prevention portfolio and research pipeline that will be presented ...

Gilead Sciences posts strong 2025 HIV growth despite a $900M headwind, as Biktarvy and Descovy lead and new launch Yeztugo gains momentum.

In his State of the Nation address President Cyril Ramaphosa announced the rollout of Lenacapavir, a six-monthly HIV prevention injection, to over 450 000 people this year.

Add Yahoo as a preferred source to see more of our stories on Google. Two men, with one looking at the camera while the other looks past the other As Congress nears a January deadline to pass a ...

In his State of the Nation Address (SONA) this week, President Cyril Ramaphosa announced that the country will begin ...

After a year of US funding cuts across global public health, including South Africa’s hard-hit HIV programmes, new realities ...

"The price has been negotiated. Scotland has access. So why are people in England still waiting?" writes Dan Glass in an op-ed for Attitude The post ‘Lenacapavir is available – how many people have ...

Zimbabwe is preparing to make one of its boldest public‑health moves in decades - rolling out a groundbreaking HIV prevention injection that could ...

Health experts warn new HIV preventive jab does not protect against other STIs, pregnancyHealth experts are welcoming the registration of a twice-yearly injection to prevent HIV, while warning that ...